David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Ingersoll Rand
IR
$30.9B
| $3.72M | ﹤0.01% |
101,446
-452,892
| -82% | -$14.9M |
|
|
VAR
1927
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
| $3.72M | ﹤0.01% |
+26,200
| New | +$3.34M |
|
|
BNY
1928
CALL
Bank of New York Mellon
BNY
$111B
| $3.72M | ﹤0.01% |
+73,900
| New | +$3.53M |
|
|
CYBR
1929
CALL
DELISTED
CyberArk
CYBR
| $3.72M | ﹤0.01% |
31,900
-27,200
| -46% | -$3.05M |
|
1930
CALL
Transocean
RIG
$6.24B
| $3.71M | ﹤0.01% |
539,500
+129,700
| +32% | +$668K |
|
1931
PUT
Dover
DOV
$27.4B
| $3.71M | ﹤0.01% |
+32,200
| New | +$3.45M |
|
|
CHS
1932
DELISTED
Chicos FAS, Inc.
CHS
| $3.71M | ﹤0.01% |
972,945
+721,269
| +287% | +$2.77M |
|
|
SGEN
1933
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $3.7M | ﹤0.01% |
+32,400
| New | +$3.44M |
|
1934
Roku
ROKU
$23.5B
| $3.7M | ﹤0.01% |
+27,623
| New | +$3.8M |
|
|
ABB
1935
CALL
DELISTED
ABB Ltd
ABB
| $3.69M | ﹤0.01% |
+153,400
| New | +$3.29M |
|
1936
PUT
Box
BOX
$4.81B
| $3.69M | ﹤0.01% |
219,900
| – | – |
|
1937
CALL
SolarEdge
SEDG
$2.06B
| $3.69M | ﹤0.01% |
38,800
+27,300
| +237% | +$2.33M |
|
1938
Corbus Pharmaceuticals
CRBP
$217M
| $3.69M | ﹤0.01% |
22,505
-2,132
| -9% | -$315K |
|
|
TMHC
1939
DELISTED
Taylor Morrison
TMHC
| $3.69M | ﹤0.01% |
168,553
-374,085
| -69% | -$8.99M |
|
1940
CALL
Novartis
NVS
$294B
| $3.68M | ﹤0.01% |
38,900
| – | – |
|
|
SCHW
1941
CALL
Charles Schwab
SCHW
$187B
| $3.68M | ﹤0.01% |
77,400
-4,700
| -6% | -$207K |
|
1942
CNX Resources
CNX
$5.32B
| $3.68M | ﹤0.01% |
415,525
+317,470
| +324% | +$2.48M |
|
|
MCHB
1943
Mechanics Bancorp
MCHB
$3.54B
| $3.68M | ﹤0.01% |
108,109
+1,875
| +2% | +$58K |
|
1944
Martin Marietta Materials
MLM
$37.8B
| $3.67M | ﹤0.01% |
13,128
+5,251
| +67% | +$1.4M |
|
|
ETFC
1945
PUT
DELISTED
E*Trade Financial Corporation
ETFC
| $3.67M | ﹤0.01% |
80,800
+41,400
| +105% | +$1.77M |
|
1946
Flotek Industries
FTK
$868M
| $3.65M | ﹤0.01% |
304,263
-6,610
| -2% | -$76.3K |
|
|
BEST
1947
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $3.65M | ﹤0.01% |
32,825
-1,141
| -3% | -$125K |
|
|
HOLI
1948
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $3.64M | ﹤0.01% |
221,993
+64,408
| +41% | +$977K |
|
|
ODT
1949
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $3.63M | ﹤0.01% |
111,997
+41,913
| +60% | +$1.3M |
|
1950
B2Gold
BTG
$7.56B
| $3.63M | ﹤0.01% |
905,952
-378,493
| -29% | -$1.34M |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw withdrew a net $3.91B in Q4 2019, closing 412 positions and reducing 1,498 holdings. Its most notable exit was Celgene Corp, an estimated $460M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Tesla worth $501M.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.